QA: Rezolute Inc in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2014_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001509261, Rezolute Inc

  xvar xval
0 AssetsCurrent 815,549
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 275,717
3 remainder_Assets 12,705
4 LiabilitiesCurrent 5,266,183
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 28,660
9 ResearchAndDevelopmentExpense 3,494
10 remainder_Expenses 6,074,727
11 remainder_Revenues 0
12 remainder_NetIncome -620,576
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 1,103,971
1 Liabilities 5,266,183
2 Expenses 6,106,881
3 Revenues 0
4 StockholdersEquity -4,162,212
5 NetIncome -6,727,457
6 ComprehensiveNetIncome -6,727,457
7 BaseVar 6,548,806
8 EconomicCapitalRatiobeforeLimitedLiability -4.96
9 EconomicCapitalRatio 0.197

Edgar->Model Mapping

Feature Distribution